Assessment of Visceral Obesity in Patients with Psoriasis by Bioimpedance Analysis

Psoriasis is regarded as a multifaceted and complex disease. Clinical manifestations of psoriasis are commonly associated with chronic inflammatory responses. Psoriasis as a skin disorder is frequently associated with metabolic syndrome (obesity, hypertension, dyslipidemia, and diabetes). Visceral fat may be linked to development of metabolic syndrome which subsequently can cause either the development or worsening of psoriasis. We measured visceral obesity in psoriatic patients with the help of bioimpedance analysis (BIA). A cross-sectional study was conducted in Razi Hospital, Tehran, Iran, in 2019. Eighty-eight patients with confirmed diagnosis of psoriasis (disease group) and 88 age- and sex- matched, healthy controls (comparison group) were enrolled to the study. Important medical information of participants including obesity parameters were assessed at baseline. Laboratory tests were performed at the hospital’s laboratory and disease severity of each patient was determined by the Psoriasis Area and Severity Index (PASI). A total of 32 (39.02%) of psoriatic patients were diagnosed with metabolic syndrome. Body mass index (BMI), visceral fat area (VFA), and percentage of body fat (PBF) were significantly higher in psoriatic patients compared to controls. Also, psoriatic patients with metabolic syndrome had higher levels of VFA, PBF, and BMI in comparison to those without metabolic syndrome. Moreover, BIA measuring of phase angle (PhA) as an indicator of cell membrane condition revealed no association with either metabolic syndrome or psoriasis. Metabolic syndrome is prevalent in psoriatic patients. Also, obesity biomarkers (e.g., VFA, PBF, and BMI) are significantly higher among patients suffering from both psoriasis and metabolic syndrome in comparison to psoriatic patients without metabolic syndrome. BIA method can help physicians for more reliable and accurate diagnosis and management of the associated comorbidities in psoriatic patients.